Connection

JEFFREY ROSEN to Gene Expression Regulation, Neoplastic

This is a "connection" page, showing publications JEFFREY ROSEN has written about Gene Expression Regulation, Neoplastic.
  1. New twists on long noncoding RNAs: from mobile elements to motile cancer cells. RNA Biol. 2020 11; 17(11):1535-1549.
    View in: PubMed
    Score: 0.412
  2. C/EBP? Isoform Specific Gene Regulation: It's a Lot more Complicated than you Think! J Mammary Gland Biol Neoplasia. 2020 03; 25(1):1-12.
    View in: PubMed
    Score: 0.404
  3. The Cellular Origin and Evolution of Breast Cancer. Cold Spring Harb Perspect Med. 2017 Mar 01; 7(3).
    View in: PubMed
    Score: 0.328
  4. Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer. Cancer Immunol Res. 2023 11 01; 11(11):1462-1479.
    View in: PubMed
    Score: 0.130
  5. Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition. Nat Commun. 2021 07 12; 12(1):4262.
    View in: PubMed
    Score: 0.111
  6. Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression. Oncogene. 2017 10 26; 36(43):5958-5968.
    View in: PubMed
    Score: 0.084
  7. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential. Oncogene. 2015 Dec 03; 34(49):5997-6006.
    View in: PubMed
    Score: 0.072
  8. Intratumoral heterogeneity in a Trp53-null mouse model of human breast cancer. Cancer Discov. 2015 May; 5(5):520-33.
    View in: PubMed
    Score: 0.072
  9. Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts. Genome Biol. 2013 Nov 12; 14(11):R125.
    View in: PubMed
    Score: 0.065
  10. Predicting drug responsiveness in human cancers using genetically engineered mice. Clin Cancer Res. 2013 Sep 01; 19(17):4889-99.
    View in: PubMed
    Score: 0.064
  11. Mammary gland development & breast cancer; connecting the dots by non-coding RNAs. J Mammary Gland Biol Neoplasia. 2012 Mar; 17(1):1-2.
    View in: PubMed
    Score: 0.058
  12. Stem cell antigen-1 (sca-1) regulates mammary tumor development and cell migration. PLoS One. 2011; 6(11):e27841.
    View in: PubMed
    Score: 0.057
  13. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. Proc Natl Acad Sci U S A. 2012 Feb 21; 109(8):2778-83.
    View in: PubMed
    Score: 0.055
  14. Small players with big roles: microRNAs as targets to inhibit breast cancer progression. Curr Drug Targets. 2010 Sep; 11(9):1059-73.
    View in: PubMed
    Score: 0.052
  15. Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer. Cancer Res. 2010 Jun 15; 70(12):4868-79.
    View in: PubMed
    Score: 0.051
  16. The epigenetic landscape of mammary gland development and functional differentiation. J Mammary Gland Biol Neoplasia. 2010 Mar; 15(1):85-100.
    View in: PubMed
    Score: 0.050
  17. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A. 2009 Aug 18; 106(33):13820-5.
    View in: PubMed
    Score: 0.049
  18. A critical role for the inflammatory response in a mouse model of preneoplastic progression. Cancer Res. 2006 Jun 01; 66(11):5676-85.
    View in: PubMed
    Score: 0.039
  19. Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland. J Cell Biol. 2002 May 13; 157(4):703-14.
    View in: PubMed
    Score: 0.029
  20. Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties. Sci Rep. 2013; 3:2687.
    View in: PubMed
    Score: 0.015
  21. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A. 2010 Aug 31; 107(35):15449-54.
    View in: PubMed
    Score: 0.013
  22. Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival. Mol Cancer Res. 2003 Dec; 1(14):1036-47.
    View in: PubMed
    Score: 0.008
  23. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation. Cancer Res. 2003 Oct 01; 63(19):6237-43.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.